ACT2 Project
Published
Supplier(s)
Value
Description
University of Birmingham (UoB) is the sponsor of ACT2 (Allogeneic Chondrocyte Therapy - A phase 2a study), an MRC funded project (MR/V027670/1). The study commenced in 2021 with the aim to develop and manufacture an allogeneic chondroprogenitor cell therapy from fresh osteochondral allografts in order to treat cartilage lesions in a single surgery. The study requires a manufacturing facility that can work with the research team to develop and validate the manufacturing process of the cell therapy product to a standard that can gain MHRA approval and thus enable the commencement of a Phase 2a human trial. Due to unforeseen circumstances UoB is no longer able to manufacture the cell therapy product and, thus an alternative manufacturing facility is required expeditiously. The UoB team must operate within the restrictions placed upon them by the funder and the current project plan. In addition to this, the administrative burden as a consequence of BREXIT makes the use of a UK labaratory the only viable option. The OsCell Laboratory at The Robert Jones and Agnes Hunt Hospital (RJAH) has the unique requirements to deliver the project within the financial and time restrictions facing the project. Lot 1: Our decision to exclusively source the OsCell laboratory to manufacture the chondrocyte therapy is founded on several irrefutable factors. The OsCell Laboratory is the only GMP facility within the UK who currently manufacture a GMP compliant chondrocyte therapy for clinic use. It is the most experienced laboratory in the UK for the manufacture of chondrocytes, with a proven track record of chondrocyte manufacture since 1997. OsCell is the only GMP laboratory in the UK with the necessary experience of process development and the validation of new therapies for cartilage repair, as well as producing cells for use in a clinical trial of a cell therapy for cartilage repair. RJAH and the OsCell Laboratory, together with Keele University, instigated and delivered the ACTIVE trial (ISRCTN48911177), which remains the largest clinical trial investigating a chondrocyte cell therapy in the world. In addition, the RJAH and OsCell Laboratory has just completed the ASCOT trial (ISRCTN98997175), a randomised controlled trial of autologous chondrocyte implantation vs. two mesenchymal stem cell (MSC) therapies, 1 of which was combined with chondrocytes. No other facility in the UK possesses the capability to furnish us with the complete suite of resources, knowledge, experience and support necessary to uphold the exceptional standards of research and innovation we strive to maintain. The funding requirements and the current project status require the manufacturer to be in a position to commence manufacture within 2 months. The location of the OsCell laboratory is unique in that it is on the same site as the Keele University researchers involved in the study. This provides the researchers with the opportunity to closely interact with the facility to enable rapid knowledge transfer and ensure, as best as possible, that the future timelines of the project are met. It is anticipated that the manufacture protocols of the new therapy can be easily embedded within the facility and minimise the training requirements, hence facilitating a relatively early adoption. In addition, the close proximity will allow for optimised training and practice, negating the need for additional ethical and administrative approvals. The use of any other facility would result in significant delays, particularly regarding training and administration, which would threaten the project timelines. The nature of the OsCell Laboratory facility is also unique in that only 1 research project at a time is accepted by the facility, guaranteeing the project will receive the necessary priority that the current imposed timelines necessitate. The Qualified Person (QP) involved in the project for the last 14 months would remain in place, ensuring continuity. No other facility can provide a QP with prior knowledge of the project and experience of currently supervising the release of manufactured chondrocytes for clinical use in a UK facility.
Timeline
Award date
19 days ago
Publish date
12 days ago
Buyer information
University of Birmingham
- Contact:
- Kseniya Samsonik
- Email:
- K.Samsonik@bham.ac.uk
Explore contracts and tenders relating to University of Birmingham
Go to buyer profileNotice topic
Source
"Find-a-Tender"To save this opportunity, sign up to Stotles for free.
Save in appTender tracking
Access a feed of government opportunities tailored to you, in one view. Receive email alerts and integrate with your CRM to stay up-to-date.
Proactive prospecting
Get ahead of competitors by reaching out to key decision-makers within buying organisations directly.
360° account briefings
Create in-depth briefings on buyer organisations based on their historical & upcoming procurement activity.
Collaboration tools
Streamline sales workflows with team collaboration and communication features, and integrate with your favourite sales tools.
Explore similar tenders and contracts
Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.
- Awarded
P2147 - Sexual Health Treatment and Prevention Services - AWARD
Birmingham City Council94,233,312 GBPPublished 7 days ago
- Awarded
Established Medicines licensing assessment support
Medicines and Healthcare products Regulatory Agency102,000 GBPPublished 27 days ago
- Awarded
Established Medicines licensing assessment support
Medicines and Healthcare products Regulatory Agency102,000 GBPPublished 27 days ago
- Awarded
Established Medicines licensing assessment support
Medicines and Healthcare products Regulatory Agency110,000 GBPPublished 27 days ago
- Awarded
Exact Sciences - Oncotype DX Breast Recurrence Score tests
Norfolk and Norwich University Hospitals NHS Foundation Trust340,202 GBPPublished 27 days ago
- Awarded
Provision of Consultant Support to the Tier 3 Specialist Weight Management Service
Wirral Community Health & Care Trust24,338 GBPPublished a month ago
- Awarded
CaptureStroke
Norfolk and Norwich University Hospitals NHS Foundation Trust145,602 GBPPublished 2 months ago
Explore other contracts published by University of Birmingham
Explore more open tenders, recent contract awards and upcoming contract expiries published by University of Birmingham.
- Awarded
Contract for the Provision of Enterprise Licence Agreement
University of Birmingham432,055 GBPPublished 24 days ago
- Awarded
Estates and Campus Strategy (Masterplan) for the University of Birmingham
University of Birmingham600,000 GBPPublished a month ago
- Awarded
Framework Agreement for the Provision of Geometric Surveying and BIM Modelling Services
University of Birmingham2,000,000 GBPPublished 3 months ago
- Awarded
Hire of celebration marquee on The Green Heart
University of Birmingham27,261 GBPPublished 3 months ago
- Awarded
Refurbishment of Former Barclays Bank Space for the University of Birmingham
University of Birmingham27,845 GBPPublished 3 months ago
- Awarded
Semestry Timetabling year 2 subscription
University of Birmingham142,850 GBPPublished 3 months ago
Explore more suppliers to University of Birmingham
Sign upExplore top buyers for public sector contracts
Discover open tenders, contract awards and upcoming contract expiries of thousands of public sector buyers below. Gain insights into their procurement activity, historical purchasing trends and more.
Explore top sources for public sector contracts
Stotles aggregates public sector contract data from every major procurement data source. We ingest this data and surface the most relevant insights for our users. Explore our list of public sector procurement data sources below.